help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hollt, V.
Right arrow Articles by Herz, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hollt, V.
Right arrow Articles by Herz, A.

Endocrinology, Vol 110, 1885-1891, Copyright © 1982 by Endocrine Society

ARTICLES

Chronic haloperidol treatment increases the level of in vitro translatable messenger ribonucleic acid coding for the beta- endorphin/adrenocorticotropin precursor proopiomelanocortin in the pars intermedia of the rat pituitary

V Hollt, I Haarmann, BR Seizinger and A Herz

Chronic treatment of rats with haloperidol (1.5 mg/kg, once daily) over a period of 7--21 days resulted in a 80--100% increase in the tissue levels of immunoreactive beta-endorphin and in the in vitro release of immunoreactive beta-endorphin from the neurointermediate pituitary. Incorporation of [3H]phenylalanine into isolated neurointermediate pituitaries of haloperidol-treated rats revealed an increase in the amount of label incorporated into the beta-endorphin/ACTH precursor proopiomelanocortin (POMC) to a similar extent (about 80%) but had essentially no effect on the conversion of the precursor into beta- lipotropin and beta-endorphin. Extraction of messenger (m) RNA from neurointermediate pituitaries followed by cell-free translation in a reticulocyte system showed an increase in the total level of translatable mRNA (about 25%). The content of translatable mRNA coding for POMC, however, was increased by 100-150%. Time-course studies revealed a parallelism between the effect of haloperidol on the level of in vitro translatable mRNA coding for POMC and the ability of the drug to increase the concentrations of beta-endorphin in the neurointermediate pituitary. A complete reversal of the effects of haloperidol was seen 2 weeks after discontinuation of the drug. These findings suggest that the chronic blockade of dopaminergic receptors by haloperidol causes a reversible increase in the beta-endorphin biosynthesis in the rat intermediate pituitary at the pretranslational level by markedly increasing the level of translatable mRNA coding for POMC.


This article has been cited by other articles:


Home page
 Ann. N. Y. Acad. Sci.Home page
B. M. CHRONWALL, D. S. HASAN, and S. A. SANDS
Axonal Plasticity in the Rat Pituitary Intermediate Lobe following Chronic D2 Receptor Modulation
Ann. N.Y. Acad. Sci., January 1, 1999; 897(1): 415 - 419.
[Full Text] [PDF]

Home page
 ScienceHome page
L. Tecott, J. Barchas, and J. Eberwine
In situ transcription: specific synthesis of complementary DNA in fixed tissue sections
Science, June 17, 1988; 240(4859): 1661 - 1664.
[Abstract] [PDF]

Home page
 ScienceHome page
T Antakly, A Sasaki, A. Liotta, M Palkovits, and D. Krieger
Induced expression of the glucocorticoid receptor in the rat intermediate pituitary lobe
Science, July 19, 1985; 229(4710): 277 - 279.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society